|
Volumn 10, Issue 9, 2002, Pages 3001-3010
|
Structural studies on bioactive compounds. Part 36: Design, synthesis and biological evaluation of pyrimethamine-based antifolates against Pneumocystis carinii
|
Author keywords
[No Author keywords available]
|
Indexed keywords
2,4 DIAMINO 5 (3 BENZOYLAMINO 4 CHLOROPHENYL) 6 ETHYLPYRIMIDINE;
2,4 DIAMINO 5 [3 (3,4,5 TRIMETHOXYBENZOYL)AMINO 4 CHLOROPHENYL] 6 ETHYLPYRIMIDINE;
2,4 DIAMINO 5 [3 [N (BENZYL) N METHYLAMINO] 4 CHLOROPHENYL] 6 ETHYLPYRIMIDINE;
2,4 DIAMINO 5 [4 CHLORO 3 (1,2,3 TRIAZOL 1 YL)PHENYL] 6 ETHYLPYRIMIDINE;
2,4 DIAMINO 5 [4 CHLORO 3 (4 PHENYL 1,2,3 TRIAZOL 1 YL)PHENYL] 6 ETHYLPYRIMIDINE;
2,4 DIAMINO 5 [4 CHLORO 3 (4 TRIMETHYLSILYL 1,2,3 TRIAZOL 1 YL)PHENYL] 6 ETHYLPYRIMIDINE;
2,4 DIAMINO 5 [4 CHLORO 3 [N (BENZYL)AMINO]PHENYL] 6 ETHYLPYRIMIDINE;
ANTIPROTOZOAL AGENT;
FOLIC ACID ANTAGONIST;
PYRIMETHAMINE;
UNCLASSIFIED DRUG;
DIHYDROFOLATE REDUCTASE;
TRIAZINE DERIVATIVE;
ANIMAL MODEL;
ANIMAL TISSUE;
ANTIPROTOZOAL ACTIVITY;
ARTICLE;
CONTROLLED STUDY;
DRUG CONFORMATION;
DRUG DESIGN;
DRUG POTENCY;
DRUG SELECTIVITY;
DRUG STABILITY;
DRUG SYNTHESIS;
IC 50;
NONHUMAN;
PNEUMOCYSTIS CARINII;
PNEUMOCYSTIS PNEUMONIA;
PROTON NUCLEAR MAGNETIC RESONANCE;
RAT;
STRUCTURE ACTIVITY RELATION;
ANIMAL;
CHEMICAL STRUCTURE;
DRUG EFFECT;
ENZYMOLOGY;
LIVER;
MYCOBACTERIUM AVIUM;
PNEUMOCYSTIS;
SPECIES DIFFERENCE;
SYNTHESIS;
TOXOPLASMA;
PNEUMOCYSTIS CARINII;
ANIMALS;
DRUG DESIGN;
FOLIC ACID ANTAGONISTS;
INHIBITORY CONCENTRATION 50;
LIVER;
MODELS, MOLECULAR;
MOLECULAR STRUCTURE;
MYCOBACTERIUM AVIUM;
PNEUMOCYSTIS;
PYRIMETHAMINE;
RATS;
SPECIES SPECIFICITY;
STRUCTURE-ACTIVITY RELATIONSHIP;
TETRAHYDROFOLATE DEHYDROGENASE;
TOXOPLASMA;
TRIAZINES;
|
EID: 0036314961
PISSN: 09680896
EISSN: None
Source Type: Journal
DOI: 10.1016/S0968-0896(02)00128-1 Document Type: Article |
Times cited : (44)
|
References (30)
|